Featured
GM ANZ role up for grabs
Pharma launches a recruitment drive to find the company's next leader with a glowing reference from the current GM who is leaving for a new organisation
Leadership & People
Is Medical Affairs the 'Jan Brady' of pharma?
The MAPA Medical Affairs Summit was told MA is like the 'middle child' of pharma in a robust debate about how best the function can unleash its true potential
Regulatory & Reimbursement
$113M Novartis drug under threat
Among a raft of prescription medicines added to the ARTG last week is the first generic version of a Novartis drug that earned $113 million in pre-rebate PBS benefits over the past year.
Leadership & People
Scientists behind Big Pharma drugs gonged
Five scientists and a Canadian-American actor behind big name drug discoveries have been recognised for their efforts at the 2026 Lasker Foundation Awards
Jobs
Regulatory & Reimbursement
Who's won an October PBS listing... already?
Nineteen days before the turn of the calendar, the Govt has announced the PBS listing of a new treatment for patients with a debilitating disease
Leadership & People
How to lead without the job title
Medical affairs heavyweights joined a panel at MAPA to outline how people can take the lead in their organisations whatever the title they have
Leadership & People
Another Country Boss departs
After 11 years working for the same Big Pharma and almost four serving on the Board of the industry body, this executive is the latest leadership departure
Latest
US Govt funds access to Aussie drug
Millions in funding will allow up to 200 people to access a drug currently in a Phase 2/3 trial, providing real-world clinical data from a broader population.
Jobs & Workplace
Global boss lands top Aussie role
Relocating to Australia from London, this global value and access high-flyer has been snapped up by J&J for a senior leadership position
Industry & Companies
Company eyes ‘golden decade’
Pharma sets an ambitious goal to establish a portfolio of more than 100 biosimilars by 2040, up substantially from the 13 it currently markets
Regulatory & Reimbursement
Butler tips more drugs to follow the 'Beast’
The Health Minister is “very confident” that other immunotherapy drug makers will submit broad PBS listing submissions following in the footsteps of a drug he referred to as the 'Beast' which has just won multi-cancer reimbursement
Industry & Companies
Industry body names new leader
After 12 years, this well-known leader who has worked tirelessly for equity in cancer care is standing down with a successor already named
Industry & Companies
'Defining moment' for Sydney viral vector facility
TGA grants licence to manufacture therapeutic goods, marking a significant milestone for the company and sovereign capability for Australia
Featured
Meet ANZ's best Medical Affairs professionals
Thirteen medical affairs professionals, some representing their teams, have been recognised for their outstanding contribution to the industry across Australia and New Zealand
Featured
On the edge: Here comes the $550B cliff fall
An industry-wide upheaval is coming to pharma with a monster patent cliff fall to hit in the next four years and even one of the world's newest blockbusters is not safe
Industry & Companies
MAPA Summit unpacks leadership in the age of AI
Attendees given insights into the way AI will change their roles and told how important it is that they exert influence independent of their job title
Jobs & Workplace
Open: Netflix-style library for Medical Affairs
A living, curated repository bringing the growing evidence base around the medical affairs function together in one place - and its free
Industry & Companies
Pharma backs Australia’s World Cup campaign
Company sponsorship of the Poweroos reflects a broader commitment to supporting people living with rare and neuromuscular conditions
Latest
Where does your State rank on patient support?
Australian States and Territories have been ranked on how well they support families who are getting treatment for cancer, and only one passed muster.
Leadership & People
Butler sidesteps 'future PM' speculation
Minister deftly sidesteps questions about growing speculation he is the Labor Party's "leader-in-waiting" when Anthony Albanese's time as PM comes to an end
Industry & Companies
Patients pick best pharma but there's a problem
When it comes to favourite pharmas, one company is a clear standout according to this patient cohort which says industry's overall corporate reputation has improved... except in one crucial area
- Regulation & Legal Which specialists are embracing AI?
- Industry & Companies GM says Australia cannot afford to fall behind
- Regulatory & Reimbursement Call for accelerated rare cancers pathway
- Regulatory & Reimbursement Company takes second tilt at a PBAC 'Yes'
- Regulatory & Reimbursement TGA approval lands in the nick of time
- Jobs & Workplace Pharma bosses call out work-life balance
- Jobs & Workplace Redundancies hit pharma spin-off
- Jobs & Workplace Pharma promotes exec to Country Lead
- Regulatory & Reimbursement Medicine moves to OTC to ease access issues
- Regulatory & Reimbursement PBS election sweetener pays off for voters
